SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRosebank Regulatory News (ROSE)

Share Price Information for Rosebank (ROSE)

Share Price is delayed by 15 minutes
Get Live Data
350.00    12.00 (3.55%)
Bid:
350.00
Ask:
352.00
Spread: 2.00 (0.571%)
Market Cap: £3.46b
ROSE Live PriceLast checked at - London Stock Exchange

Intraday Rosebank Share Chart

Replacement Option Grant

4 Sep 2013 13:30

RNS Number : 2277N
Rose Petroleum PLC
04 September 2013
Β 

ο»Ώ

The following announcement replaces the announcement released at 7.30a.m. on 3 September 2013 under RNS number 0793N. The last paragraph has been amended to state the correct total number of options outstanding and the percentage they represent. All other details remain the same. The full text of the amended announcement is set out below:

Rose Petroleum plc (the "Company")

Β 

Grant of Options

Β 

The Company has today granted options over ordinary shares of 0.1p in the Company ("Ordinary Shares") under the Company's share option schemes ("Options"). A total of 70,400,000 Options have been granted to certain directors and senior employees as set out below:

Β 

Name of Director / employee

Number of Options granted

Exercise price per Option

Total number of options now held

Richard Kilmorey, Chairman

7,500,000

1.125p

8,250,000

Matthew Idiens, CEO

15,800,000

1.125p

21,800,000

Kelly Scott, Technical Director

23,800,000

0.475p

23,800,000

Fivos Spathopoulos

15,800,000

0.475p

15,800,000

Matthew Frost

7,500,000

0.475p

7,500,000

Β 

Each Option is exercisable into one ordinary share of 0.1p each in the Company and can be exercised as to a third after one year, a third after two years and a third after three years up until 1 September 2023.

Β 

The new Options granted today represent approximately 8.88% of the Company's current issued share capital and there are now a total of 91,800,000 options over Ordinary Shares outstanding, representing approximately 11.6% of the Company's current issued share capital.

Β 

For further information, please contact:

Β 

Rose Petroleum Plc

Matthew Idiens, CEO

+44 (0) 20 7225 4595

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/Alex Price

Β 

+44 (0) 20 3328 5656

Bankside Consultants

Simon Rothschild

+44 (0) 20 7367 8888

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCNKQDBBBKDQCK
Date   Source Headline
31st Dec 20191:00 pmRNSTotal Voting Rights
3rd Dec 201912:27 pmRNSIssue of Equity and change to TVR
29th Nov 20195:00 pmRNSTotal Voting Rights
22nd Nov 20194:52 pmRNSHolding(s) in Company
21st Nov 201912:43 pmRNSResult of General Meeting and change to TVR
14th Nov 20192:10 pmRNSHolding(s) in Company
8th Nov 20194:12 pmRNSHolding(s) in Company
4th Nov 20192:16 pmRNSDirector/PDMR shareholding
4th Nov 20197:05 amRNSIssue of equity and notice of general meeting
4th Nov 20197:00 amRNSProposed Acquisition-McCoy Interest & Fundraising
14th Oct 20197:00 amRNSRestructuring of the Paradox project
30th Sep 20197:00 amRNSHalf-year Report
3rd Sep 20197:00 amRNSDirectorate Changes and Board Restructuring
2nd Sep 201910:59 amRNSHolding(s) in Company
30th Aug 20195:00 pmRNSTotal Voting Rights
22nd Aug 20197:00 amRNSIssue of equity and change to total voting rights
30th Jul 201912:46 pmRNSResult of AGM and update on Board composition
10th Jul 20193:01 pmRNSHolding(s) in Company
28th Jun 20197:00 amRNSBoard appointment and update
28th Jun 20197:00 amRNSFinal Results
27th Jun 20197:00 amRNSNotice of Annual Results
3rd Jun 20197:00 amRNSTotal Voting Rights
24th May 20197:00 amRNSSubscription completion, board appointment & TVR
20th May 20197:00 amRNSIssue of equity and Board Changes
30th Apr 20197:00 amRNSUpdated Corporate Presentation
23rd Apr 20197:00 amRNSDirectorate Change
12th Apr 20193:40 pmRNSHolding(s) in Company
12th Apr 20197:00 amRNSDirector/PDMR Shareholding
11th Apr 20197:00 amRNSIssue of equity and Board Changes
28th Mar 20197:00 amRNSUpdate & Proposed Board Changes
26th Mar 20199:41 amRNSHolding in Company - Correction
12th Mar 20194:17 pmRNSHolding(s) in Company
5th Mar 20196:09 pmRNSHolding(s) in Company
5th Mar 20199:12 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSAcquisition of additional acreage in Paradox Basin
7th Jan 20197:00 amRNSSchlumberger Study Results
6th Dec 20187:00 amRNSOperations Update
27th Nov 20187:00 amRNSDatabase Agreement & North Wash Vanadium update
1st Nov 20187:00 amRNSBLM Approval for Permit to Drill GV 22-1 well
3rd Oct 20187:00 amRNSHolding(s) in Company
25th Sep 20187:00 amRNSHalf-year Report
18th Jul 20181:46 pmRNSHolding(s) in Company
18th Jul 20181:44 pmRNSHolding(s) in Company
3rd Jul 20181:47 pmRNSCantor Fitzgerald initiates research coverage
28th Jun 201811:28 amRNSResult of AGM
28th Jun 20187:00 amRNSInterviews with CEO Matthew Idiens
22nd Jun 20187:00 amRNSCPR - Maiden Contingent Resource and NPV Estimate
19th Jun 20187:00 amRNSAppointment of Financial Adviser and Joint Broker
14th Jun 20187:00 amRNSHolding(s) in Company
6th Jun 20187:00 amRNSFinal Results & notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.